• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用核糖体疫苗D - 53经口刺激后人扁桃体中特异性抗体形成细胞的增加。

Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine.

作者信息

Faure G C, Béné M C, Simon C, Quantain A

机构信息

Laboratoire d'Immunologie, UFR Sciences Médicales de Nancy, Vandoeuvre, France.

出版信息

Int J Immunopharmacol. 1990;12(3):315-20. doi: 10.1016/0192-0561(90)90087-4.

DOI:10.1016/0192-0561(90)90087-4
PMID:2184137
Abstract

Thirty subjects who had received an oral ribosomal vaccine to common bacteria of upper respiratory tract infections, and ten controls were tonsillectomized for recurrent infections or rhonchologic pathology. A three-step indirect immunofluorescence technique was used to identify and enumerate specific antibody forming cells (SAFC) in their tonsils. Plasma-cells specific of the four strains being constituents of the oral vaccine (H. influenzae, K. pneumoniae, S. pyogenes and S. pneumoniae) were observed in all samples. The numbers of SAFC were significantly higher in the subjects who had received the oral vaccine. These results support the efficiency or oral immunization in increasing local defenses, even at distance from the sensitized gut-associated lymphoid tissue. These data provide evidence for the homing phenomenon in human mucosae associated lymphoid tissue (MALT).

摘要

30名曾接受针对上呼吸道感染常见细菌的口服核糖体疫苗的受试者,以及10名因反复感染或呼吸道疾病而接受扁桃体切除术的对照者。采用三步间接免疫荧光技术来识别和计数他们扁桃体中的特异性抗体形成细胞(SAFC)。在所有样本中均观察到了针对口服疫苗的四种菌株(流感嗜血杆菌、肺炎克雷伯菌、化脓性链球菌和肺炎链球菌)的特异性浆细胞。接受口服疫苗的受试者中的SAFC数量显著更高。这些结果支持了口服免疫在增强局部防御方面的有效性,即使远离致敏的肠道相关淋巴组织。这些数据为人类黏膜相关淋巴组织(MALT)中的归巢现象提供了证据。

相似文献

1
Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine.用核糖体疫苗D - 53经口刺激后人扁桃体中特异性抗体形成细胞的增加。
Int J Immunopharmacol. 1990;12(3):315-20. doi: 10.1016/0192-0561(90)90087-4.
2
Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study.细菌裂解物和核糖体作为特异性免疫反应的诱导剂:一项比较研究。
Scand J Immunol. 1993 Nov;38(5):496-8. doi: 10.1111/j.1365-3083.1993.tb02594.x.
3
Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.核糖体疫苗(D 53)预防耳鼻喉科疾病中细菌感染发作有效性的多中心研究。
Arzneimittelforschung. 1980;30(1a):214-20.
4
Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes.用细菌核糖体口服治疗儿童后外周血和扁桃体中的抗体产生细胞。
Int J Immunopharmacol. 1994 Jul;16(7):497-505. doi: 10.1016/0192-0561(94)90101-5.
5
Bacterial crude extracts or ribosomes are recognized similarly by peripheral and mucosal B cells.外周B细胞和黏膜B细胞对细菌粗提物或核糖体的识别方式相似。
FEMS Immunol Med Microbiol. 1994 Nov;10(1):11-8. doi: 10.1111/j.1574-695X.1994.tb00005.x.
6
Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections.
J Allergy Clin Immunol. 1996 Aug;98(2):451-9. doi: 10.1016/s0091-6749(96)70170-7.
7
Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.7至15个月大婴儿对b型流感嗜血杆菌-CRM197结合疫苗和多糖疫苗序贯免疫的反应。
Am J Dis Child. 1991 Aug;145(8):898-900. doi: 10.1001/archpedi.1991.02160080076024.
8
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.七价肺炎球菌CRM197结合疫苗在婴幼儿中的安全性和免疫原性。
Pediatr Infect Dis J. 1999 Sep;18(9):757-63. doi: 10.1097/00006454-199909000-00004.
9
Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.一种新型疫苗(细菌核糖体与膜佐剂的组合)预防细菌性呼吸道感染。1. 概述。
Arzneimittelforschung. 1980;30(1a):196-8.
10
Specific antibody-producing cells in humans after oral immunization with a ribosomal vaccine Ribomunyl.用核糖体疫苗Ribomunyl口服免疫后人体内产生特异性抗体的细胞
Adv Exp Med Biol. 1995;371B:1563-6.

引用本文的文献

1
Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study.多价细菌溶解产物和自身疫苗对潜在病原体在上呼吸道细菌定植的有效性:一项随机研究。
Med Sci Monit. 2015 Oct 5;21:2997-3002. doi: 10.12659/MSM.893779.
2
Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.使用核糖体免疫治疗剂预防儿童反复呼吸道感染:一项临床综述。
Paediatr Drugs. 2006;8(4):235-43. doi: 10.2165/00148581-200608040-00003.
3
Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adults.
免疫预防在预防成人复发性感染性鼻炎中的成本效益
Pharmacoeconomics. 1998 Sep;14(3):313-22. doi: 10.2165/00019053-199814030-00007.
4
Pharmacology of ribosomal immunotherapy.核糖体免疫疗法的药理学
Drugs. 1997;54 Suppl 1:33-6. doi: 10.2165/00003495-199700541-00009.
5
Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunisation with a ribosomal immunostimulant.用核糖体免疫刺激剂口服免疫后,特异性唾液IgA对肺炎链球菌黏附的抑制作用。
Drugs. 1997;54 Suppl 1:29-32. doi: 10.2165/00003495-199700541-00008.
6
From Peyer's patches to tonsils. Specific stimulation with ribosomal immunotherapy.从派尔集合淋巴结到扁桃体。核糖体免疫疗法的特异性刺激。
Drugs. 1997;54 Suppl 1:24-8. doi: 10.2165/00003495-199700541-00007.
7
Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study.肺炎克雷伯菌、肺炎链球菌、化脓性链球菌、流感嗜血杆菌的核糖体组分以及肺炎克雷伯菌膜组分(Ribomunyl)在预防感染性鼻炎临床复发中的有效性。一项多中心双盲安慰剂对照研究的结果。
Eur Arch Otorhinolaryngol. 1997;254(8):372-5. doi: 10.1007/BF01642553.